Reduction of Particle Size of Drug Substance for Low-Dose Drug Products

Formulation and Analytical Development for Low-Dose Oral Drug Products

Volumn , Issue , 2008, Pages 205-222

  Burcham, Christopher L ^a   Collins, Paul C ^a   Jarmer, Daniel J ^a   Seibert, Kevin D ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

Reduction of particle size of drug substance for low dose drug products; Reduction of particle size of drug substance using crystallization technologies; Supercritical fluid crystallization (SFC)

Indexed keywords

EID: 84884594975     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470386361.ch8     Document Type: Chapter

References (47)

1. Amidon GL, Lennernas H, Shah VP, Crison JR. 1995. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm. Res. 12: 413-420.
2. Oh DM, Curl R, Amidon G. 1993. Estimating the fraction dose absorbed from suspensions of poorly soluble compounds in humans: A mathematical model. Pharm. Res. 10:264-270.
3. Waiver of in vivo bioavailability and bioequivalence studies for immediate-release solid oral dosage forms based on a biopharmaceutics classification system. U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER), August 2000.
4. Rohrs BR, Amidon GE, Meury RH, Secreast PJ, King HM, Skoug CJ. 1996. Particle size limits to meet USP content uniformity criteria for tablets and capsules. J. Pharm. Sci. 95(5): 1049-1059.
5. Popov KI, Krstic SB, Obradovic MC, Pavlovic MG, Irvanovic ER. 2003. The effect of the particle shape and structure on the flowability of electrolytic copper powder. I. Modeling of a representative powder particle. J. Seb. Chem. Soc. 68(10): 771-777.
6. Tan SB, Newton JM. 1990. Powder flowability as an indication of capsule filling performance. Int. J. Pharm. 61: 145-155.
7. Danjo K, Kinoshita K, Kitagawa K, Iida K, Sunada H, Otsuka A. 1989. Effect of particle shape on the compaction and flow properties of powders. Chem. Pharm. Bull. 37(11):3070-3073.
8. Zeng XM, Martin GP, Tee SK, Ghoush AA, Marriott C. 1999. Effects of particle size and adding sequence of fine lactose on the deposition of salbutamol sulfate from a dry powder. Int. J. Pharm. 182(2): 133-144.
9. Shoyele SA, Cawthorne S. 2006. Particle engineering techniques for inhaled biopharmaceuticals. Adv. Drug Deliv. Rev. 58(9-10): 1009-1029.
10. Gonda I. 1992. Targeting by deposition. In: Hickey AJ, editor. Pharmaceutical inhalation aerosol technology. New York: Marcel Dekker; 61-82.
11. Hinds WC. 1982. Aerosol technology. New York: John Wiley and Sons.
12. Fisher E. 2006. Milling of active pharmaceutical ingredients. In: Encyclopedia of pharmaceutical technology, 3rd ed. Informa Healthcare; 2339-2351.
13. Liotta V, Sabesan V. 2004. Monitoring and feedback control of supersaturation using ATR-FTIR to produce and active pharmaceutical ingredient of a desired crystal size. OPR&D 8: 488-494.
14. Dennehy RD. 2003. Particle engineering using power ultrasound. OPR&D 7: 1002-1006.
15. Kim S, Lotz B, Lindrud M, Girard K, Moore T, Nagarajan K, Alvarez M, Lee T, Nikfar F, Davidovich M, Srivastava S, Kiang S. 2005. Control of particle properties of a drug substance by crystallization engineering and the effect on drug product formulation. OPR&D 9: 894-901.
16. Paul EL, Tung HH, Midler M. 2005. Organic crystallization processes. Powder Technol. 150(2): 133-143.
17. Price R, Young PM. 2005. On the physical transformations of processed pharmaceutical solids. Micron 36: 519-524.
18. Urban K,Wagner G, Schaffner D, Röglin D, Ulrich J. 2006. Rotor-stator and disc systems for emulsification processes. Chem. Engng Technol. 29(1): 24-31.
19. Kwade A, Schwedes J. 2007. Wet grinding in stirred media mills. In: Handbook of powder technology; 229-249.
20. Russell WB, Saville DA, Schowalter WR. 1991. Colloidal dispersions. New York:Cambridge University Press.
21. Beach S, Latham D, Sidgwick C, Hanna M, York P. 1999. Control of the physical form of salmeterol xinafoate. Org. Process Res. Dev. 3: 370-376.
22. Baldyga J, Bourne JR. Turbulent mixing and chemical reactions. New York: JohnWiley & Sons.
23. Shekunov BY, Baldyga J, York P. 2001. Particle formation by mixing with supercritical antisolvent at high Reynolds numbers. Chem. Engng Sci. 56: 2421-2433.
24. Demyanovich RJ, Bourne JR. 1989. Rapid micromixing by the impingement of thin liquid sheets. 2. Mixing study. Ind. Engng Chem. Res. 28: 825-830.
25. Demyanovich RJ, Bourne JR. 1989. Rapid micromixing by the photographic study of the impingement of thin liquid sheets. 1. A flow pattern. Ind. Engng Chem. Res. 28: 830-839.
26. Mahajan AJ, Kirwan DJ. 1996. Micromixing effects in a two-impinging-jets precipitator. AIChE J. 42: 1801-1814.
27. Johnson BK, Prud'homme RK. 2003. Chemical processing and micromixing in confined impinging jets. AIChE J. 49: 2264-2282.
28. Midler M, Paul EL, Whittington E, Futran M, Liu P, Hsu J, Pan S. 1994. Crystallization method to improve crystal structure and size. U.S. patent 5,314,506.
29. Linrud MD, Kim S, Wei C. 2001. Sonic impinging jet crystallization apparatus and process. U.S. patent 6,302,958.
30. Paul EL, Tung HH, Midler M. 2005. Organic crystallization processes. Powder Technol. 150: 133-143.
31. Am Ende D, Crawford TC, Weston NP. 2003. Reactive crystallization method to improve particle size. U.S. patent 5,471,001.
32. Palakodaty S, York P. 1999. Phase behavior effects on particle formation processes using supercritical fluids. Pharm. Res. 16(7): 976-985.
33. Kordikowski A, Shekunov T, York P. 2001. Polymorph control of sulfathiazole in supercritical CO2. Pharm. Res. 18(5): 682-688.
34. Jarmer DJ, Lengsfeld CS, Randolph TW. 2006. Scale-up criteria for an injector with a confined mixing chamber during precipitation with a compressed fluid antisolvent. J. Supercritical Fluids 37: 242-253.
35. Cashdollar K. 1996. Coal dust explosivity. J. Loss Prev. Process Ind. 9(1): 65-76.
36. Nifuku M, Koyanaka S, Ohya H, Barre C, Hatori M, Fujiwara S, Horiguchi S, Sochet I. 2007. Ignitability characteristics of aluminium and magnesium dusts that are generated during the shredding of post-consumer wastes. J. Loss Prev. Process Ind. 20: 322-329.
37. Kalker N, Schecker H. 1979. Theoretische uberlegungen zum einfluss der teilchengrosse auf die mindestzundenergie von stauben. Chem. Ing. Technol. 51: 1248-1249.
38. Eckhoff RK. 2003. Dust explosions in the process industries, 3rd ed. Gulf Professional Publishing.
39. Shelley S. 2007. High-shear mixers: still widely misunderstood. Chem. Engng Prog. 103(11): 7-12.
40. Lee I, Variankaval N, Lindemann C, Starbuck C. 2004. Rotor-stator milling of APIs- emperical scale up parameters and theoretical relationships between the morphology and breakage of crystals. Am. Pharm. Rev. 7(5): 120-123.
41. Atiemo-Obeng V, Calabrese R. 2003. Rotor stator mixing devices. In: Paul EL, Atiemo-Obeng V, Kresta S, editors. Handbook of industrial mixing, 1st ed. New York: John Wiley & Sons.
42. Galan O, Barton GW, Romagnoli JA. 2002. Robust control of a SAG mill. Powder Technol. 124: 264-271.
43. Holve DJ, Harvill TL. 1996. Particle size distribution measurements for in-process monitoring and control. Adv. Powder Metal. Part. Mat. 1(4): 81-93.
44. Collin A. 1997. Online control of particle size distribution. Spectra Anal. 26(196): 31-33.
45. Terray M. 2001. Process improvements for leading manufacturer of glass beads. Rec. Prog. Gen. Procedes 15: 557-560.
46. Harvill TL, Hoog JH, Holve DJ. 1995. In-process particle size distribution measurements and control. Part. Syst. Charact. 12(6): 309-313.
47. Collins PC, Roginski RT. 2006. Feed-forward modeling approach to particle size control in milling operations. AIChE Annual Meeting, San Francisco, CA, November.